A Study To Assess The Safety And Tolerability Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT00372112
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
68
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
GW642444
OTHER:
Placebo
Sponsor
GlaxoSmithKline